<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Methods Mol Biol</journal-id><journal-id journal-id-type="iso-abbrev">Methods Mol Biol</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Methods in molecular biology (Clifton, N.J.)</journal-title></journal-title-group><issn pub-type="ppub">1064-3745</issn><issn pub-type="epub">1940-6029</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12046528</article-id><article-id pub-id-type="pmcid-ver">PMC12046528.1</article-id><article-id pub-id-type="pmcaid">12046528</article-id><article-id pub-id-type="pmcaiid">12046528</article-id><article-id pub-id-type="manuscript-id">NIHMS2071756</article-id><article-id pub-id-type="pmid">34784028</article-id><article-id pub-id-type="doi">10.1007/978-1-0716-1900-1_1</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2071756</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2071756</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Vaccine Design by Reverse Vaccinology and Machine Learning</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Ong</surname><given-names initials="E">Edison</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>He</surname><given-names initials="Y">Yongqun</given-names></name><xref rid="A3" ref-type="aff">3</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI, USA.</aff><aff id="A2"><label>2</label>GlaxoSmithKline Vaccines, Rixensart, Belgium.</aff><aff id="A3"><label>3</label>Center of Computational Medicine and Bioinformatics, Unit for Laboratory Animal Medicine, Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI, USA.</aff><pub-date pub-type="ppub"><year>2022</year></pub-date><volume>2414</volume><issue-id pub-id-type="pmc-issue-id">487764</issue-id><fpage>1</fpage><lpage>16</lpage><pub-history><event event-type="nihms-submitted"><date><day>17</day><month>04</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>02</day><month>05</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>02</day><month>05</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-05-03 00:25:37.317"><day>03</day><month>05</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2071756.pdf"/><abstract id="ABS1"><p id="P1">Reverse vaccinology (RV) is the state-of-the-art vaccine development strategy that starts with predicting vaccine antigens by bioinformatics analysis of the whole genome of a pathogen of interest. Vaxign is the first web-based RV vaccine prediction method based on calculating and filtering different criteria of proteins. Vaxign-ML is a new Vaxign machine learning (ML) method that predicts vaccine antigens based on extreme gradient boosting with the advance of new technologies and cumulation of protective antigen data. Using a benchmark dataset, Vaxign-ML showed superior performance in comparison to existing open-source RV tools. Vaxign-ML is also implemented within the web-based Vaxign platform to support easy and intuitive access. Vaxign-ML is also available as a command-based software package for more advanced and customizable vaccine antigen prediction. Both Vaxign and Vaxign-ML have been applied to predict SARS-CoV-2 (cause of COVID-19) and <italic toggle="yes">Brucella</italic> vaccine antigens to demonstrate the integrative approach to analyze and select vaccine candidates using the Vaxign platform.</p></abstract><kwd-group><kwd>Vaccine</kwd><kwd>Antigen</kwd><kwd>Reverse vaccinology</kwd><kwd>Machine learning</kwd><kwd>Vaxign</kwd><kwd>Vaxign-ML</kwd><kwd>Vaxitop</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>